What Is the New Treatment for Dry Eyes in 2024?

A Look at the Dry-Eye Treatment Pipeline - Review of Ophthalmology

SURF-100 (mycophenolate sodium and betamethasone sodium phosphate) targets chronic dry-eye disease while SURF-200 (betamethasone) is designed to ...

First patient dosed in vezocolmitide phase 3 clinical trial for ...

Stuart Therapeutics announced the first patient first visit (FPFV) for the company's Phase 3 clinical trial of ST-100 (vezocolmitide), in patients diagnosed ...

2023 New Treatments for Dry Eyes in LA - iLux²® - BlephEx® - IPL

The ophthalmologists at our state-of-the-art facility offer the latest treatments for dry eye in 2023, including BlephEx, intense pulsed light (IPL) therapy, ...

New advances in medical management of dry eye - PubMed

New advances in medical management of dry eye: optimizing treatment strategies for enhanced relief. Int Ophthalmol. 2024 Feb 9;44(1):49. doi: 10.1007/s10792 ...

Recent United States Developments in the Pharmacological ...

GmbH N: novaliq announces FDA approval of VEVYE™ (cyclosporine ophthalmic solution) 0.1%, for the treatment of the signs and symptoms of dry eye ...

Impact of dry eye disease treatment on patient quality of life - Frontiers

VTP is a novel therapy option, particularly for DED caused by MGD (195, 253). VTP offers a convenient solution for individuals with MGD-related dry eye, ...

Improved Dry Eye Drugs for 2022 and Beyond

Dry eye is an ocular surface disease (OSD). Dry eye is one of the most common ocular surface diseases, or OSDs. · New dry eye treatments may be ...

Not a Dry Eye in the House: An Overview of New Drugs

The 0.03 mg varenicline nasal spray (Tyrvaya®, Oyster Point Pharma, Inc., Princeton, NH) is FDA approved to treat signs and symptoms of dry eye ...

Dry eye paradise: FDA green-lights Miebo as first and only eye drop ...

“Miebo from Bausch + Lomb has just arrived as the newest treatment option to help improve tear film homeostasis.” Matossian noted that with the ...

FDA approves new medication for dry eye disease

The US Food and Drug Administration approved Xiidra (lifitegrast ophthalmic solution) for the treatment of signs and symptoms of dry eye disease.

Dry Eye: Symptoms, Common Causes & Treatment - Cleveland Clinic

Place a warm compress over your eyes. Purchase a heat mask for eyes at any drug store and leave it on your eyes for 10 minutes. This can help ease your symptoms ...

2024 Will See Major Advances in Glaucoma Care - Medscape

Late last year, the US Food and Drug Administration (FDA) approved three new treatments for dry eye disease (DED) and one new procedure for ...

The 2024 Dry Eye Report - Eyes On Eyecare

However, in 2024, clinicians ranked patient education on lifestyle and environmental changes followed by daily eyelid hygiene therapy over ...

2024 Dry Eye Treatments: Latest Options For Dry Eyes - eyeFACTS

iTear100 is a new artificial tear product that was developed specifically for the treatment of dry eye syndrome. It contains a unique blend of ingredients that ...

Dry Eye Drugs: What's New and What's Next - Review of Optometry

Eysuvis (loteprednol etabonate ophthalmic suspension 0.25%, Alcon). This corticosteroid eye drop is used for the treatment of DED flares. In ...

Latest treatment for dry eye syndrome: What is it?

New treatments for dry eye syndrome include new prescription medications and pulsed light therapy. Learn more here.

The Best Eye Drops for Dry Eye (Plus Home Remedies) - GoodRx

Eysuvis (loteprednol): This is a corticosteroid eye drop that reduces inflammation related to dry eye. It should be applied 4 times per day for ...

Dry Eye | National Eye Institute

If this is the cause of your dry eye, your eye doctor may suggest surgery to fix your eyelids and help your tears stay on your eyes. This treatment is not very ...

Breakthrough Dry Eye treatment | CK Eyelid Plastic Surgery

Envision is the new, revolutionary in-office technology offering procedures for the treatment of meibomian gland dysfunction (MGD) and the symptoms of dry eye.

Optometry in 2024: What to Expect for the New Year

Meibo® (Bausch + Lomb) and Xdemvy® (Tarsus) received FDA approval this year and the drugs have shown promise for treating evaporative DED and ...